Ocular Therapeutix (OCUL) Net Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3,082.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,120.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -653.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,849.00
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn -24,552.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -24,552.00
Dec 31, 2025 -20,553.00
Sep 30, 2025 -18,489.00
Jun 30, 2025 -25,145.00
Mar 31, 2025 -37,472.00
Dec 31, 2024 -13,326.00
Sep 30, 2024 -14,037.00
Jun 30, 2024 -10,422.00
Mar 31, 2024 -3,726.00
Dec 31, 2023 -598.00
Sep 30, 2023 5,061.00
Jun 30, 2023 3,196.00
Mar 31, 2023 -2,976.00
Dec 31, 2022 1,257.00
Sep 30, 2022 -1,842.00
Jun 30, 2022 1,110.00
Mar 31, 2022 15,036.00
Dec 31, 2021 5,833.00
Sep 30, 2021 9,317.00
Jun 30, 2021 106,001.00
Mar 31, 2021 39,584.00
Dec 31, 2020 80,062.00
Sep 30, 2020 268,636.00
Jun 30, 2020 226,821.00
Mar 31, 2020 344,151.00
Dec 31, 2019 243,299.00
Sep 30, 2019 6,026.00
Jun 30, 2019 -138,468.00
Mar 31, 2019 -8,704.00
Dec 31, 2018 -76,183.00
Sep 30, 2018 -3,662.00
Jun 30, 2018 213,779.00
Mar 31, 2018 -67,527.00
Dec 31, 2017 -18,115.00
Sep 30, 2017 -96,591.00
Jun 30, 2017 -167,280.00
Mar 31, 2017 -76,749.00
Dec 31, 2016 19,055.00
Sep 30, 2016 2.61 Mn
Jun 30, 2016 -41,463.00
Mar 31, 2016 57,826.00
Dec 31, 2015 -112,470.00
Sep 30, 2015 -2.30 Mn
Jun 30, 2015 441,424.00
Mar 31, 2015 2.28 Mn